New York S 8285: Relates to the Volunteer and Exempt Fireman's Benevolent Association of Nassau county

Status: SIGNED CHAP.196 (as of 2020-09-21)

State: New York · Session: 2019-2020 · Bill: S 8285

Sponsors: BROOKS

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 - This bill is not active in this session.

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S08285 Summary:

BILL NOS08285 

&nbsp

SAME ASSAME AS A05852-A

&nbsp

SPONSORSKOUFIS

&nbsp

COSPNSRASHBY, RHOADS, TEDISCO, WEIK

&nbsp

MLTSPNSR

&nbsp

Add §398-g, Gen Bus L

&nbsp

Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.

Go to top S08285 Actions:

BILL NOS08285 

&nbsp

05/30/2025REFERRED TO CONSUMER PROTECTION

06/12/2025COMMITTEE DISCHARGED AND COMMITTED TO RULES

06/12/2025ORDERED TO THIRD READING CAL.1924

06/12/2025SUBSTITUTED BY A5852A

&nbspA05852 AMEND=A Steck

&nbsp02/24/2025referred to consumer affairs and protection

&nbsp05/14/2025amend and recommit to consumer affairs and protection

&nbsp05/14/2025print number 5852a

&nbsp05/19/2025reported referred to codes

&nbsp05/28/2025reported referred to rules

&nbsp06/04/2025reported 

&nbsp06/04/2025rules report cal.389

&nbsp06/04/2025ordered to third reading rules cal.389

&nbsp06/04/2025passed assembly

&nbsp06/04/2025delivered to senate

&nbsp06/04/2025REFERRED TO RULES

&nbsp06/12/2025SUBSTITUTED FOR S8285

&nbsp06/12/20253RD READING CAL.1924

&nbsp06/12/2025PASSED SENATE

&nbsp06/12/2025RETURNED TO ASSEMBLY

&nbsp12/08/2025delivered to governor

&nbsp12/19/2025signed chap.655

&nbsp12/19/2025approval memo.37

Go to topS08285 Committee&nbspVotes:

Go to topS08285 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS08285 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 8285

 2025-2026 Regular Sessions

 IN SENATE

 May 30, 2025
 ___________

 Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when
 printed to be committed to the Committee on Consumer Protection

 AN ACT to amend the general business law, relating to regulating the
 sale of kratom products

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The general business law is amended by adding a new section
 2 398-g to read as follows:
 3 § 398-g. Kratom package labeling. 1. For the purposes of this section,
 4 the following terms shall have the following meanings:
 5 (a) "Kratom" means both Mitragyna speciosa, a tree native to Southeast
 6 Asia, and the products derived from its leaves that are marketed as
 7 herbal supplements.
 8 (b) "All natural" means a product that contains no artificial ingredi-
 9 ents or added colors and is minimally processed.
 10 2. On each package of any kratom product sold or delivered by a
 11 manufacturer within this state on or after January first, two thousand
 12 twenty-six, there shall be printed thereon or attached thereto a warning
 13 of such product's lack of federal food and drug administration approval
 14 and such kratom products' known side effects. Such warning shall be in
 15 a font not less than twelve-point type and in a color in contrast with
 16 the package containing such kratom product, and shall contain the
 17 following statement:
 18 "WARNING
 19 This product has not been approved by the FDA. Side effects may include
 20 nausea, agitation, hallucinations, difficulty breathing, liver damage,
 21 and death"
 22 3. No kratom product shall be advertised as nor shall the packaging of
 23 such kratom product suggest, state, or imply that such kratom product is
 24 all natural.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD09239-03-5

 S. 8285 2

 1 4. Any manufacturer in violation of this section shall be subject to a
 2 civil penalty of not more than five hundred dollars for a first
 3 violation and not more than one thousand dollars for a second or subse-
 4 quent violation.
 5 § 2. This act shall take effect one year after it shall have become a
 6 law.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps

View New York S 8285 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.